Increased mutant KRAS gene dosage drives pancreatic cancer progression: evidence for wild-type KRAS as a tumor suppressor?
- PMID: 30498719
- PMCID: PMC6230847
- DOI: 10.21037/hbsn.2018.07.03
Increased mutant KRAS gene dosage drives pancreatic cancer progression: evidence for wild-type KRAS as a tumor suppressor?
Conflict of interest statement
Conflicts of Interest: The author has no conflicts of interest to declare.
Comment on
-
Evolutionary routes and KRAS dosage define pancreatic cancer phenotypes.Nature. 2018 Feb 1;554(7690):62-68. doi: 10.1038/nature25459. Epub 2018 Jan 24. Nature. 2018. PMID: 29364867 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous